Osang Healthcare Co.,Ltd (KOSDAQ:036220)
South Korea
· Delayed Price · Currency is KRW 12,690
+200 (1.60%)
At close: Dec 5, 2025
Osang Healthcare Co.,Ltd Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 119,031 | 80,488 | 355,847 | 193,893 | 132,327 | 257,967 | Upgrade
|
| Other Revenue | -0 | - | - | - | -0 | - | Upgrade
|
| Revenue | 119,031 | 80,488 | 355,847 | 193,893 | 132,327 | 257,967 | Upgrade
|
| Revenue Growth (YoY) | 57.22% | -77.38% | 83.53% | 46.53% | -48.70% | 412.01% | Upgrade
|
| Cost of Revenue | 68,363 | 54,918 | 134,739 | 95,860 | 84,710 | 67,605 | Upgrade
|
| Gross Profit | 50,668 | 25,570 | 221,108 | 98,033 | 47,617 | 190,362 | Upgrade
|
| Selling, General & Admin | 30,492 | 27,161 | 56,067 | 32,776 | 22,372 | 19,725 | Upgrade
|
| Research & Development | 20,169 | 20,336 | 16,638 | 12,107 | 9,281 | 6,487 | Upgrade
|
| Amortization of Goodwill & Intangibles | 218.93 | 214.2 | 178.57 | 218.32 | 238.9 | 270.03 | Upgrade
|
| Other Operating Expenses | 1,475 | 1,152 | 904.7 | 737.64 | 638.45 | 510.53 | Upgrade
|
| Operating Expenses | 53,219 | 50,136 | 78,768 | 48,778 | 54,724 | 29,682 | Upgrade
|
| Operating Income | -2,551 | -24,566 | 142,339 | 49,255 | -7,106 | 160,680 | Upgrade
|
| Interest Expense | -27.17 | -27.17 | -58.94 | -25.13 | -15.38 | -351.29 | Upgrade
|
| Interest & Investment Income | 1,600 | 1,600 | 3,397 | 677.49 | 831.5 | 1,007 | Upgrade
|
| Earnings From Equity Investments | 2,222 | -2,791 | 925.89 | 259.8 | 913.21 | 733.43 | Upgrade
|
| Currency Exchange Gain (Loss) | 824.39 | 2,672 | 7,649 | 2,132 | 4,054 | -6,621 | Upgrade
|
| Other Non Operating Income (Expenses) | -4,727 | 125.58 | -62.34 | 309.81 | 35.31 | 10.71 | Upgrade
|
| EBT Excluding Unusual Items | -2,660 | -22,987 | 154,190 | 52,609 | -1,287 | 155,459 | Upgrade
|
| Gain (Loss) on Sale of Investments | -56.54 | -56.54 | -104.99 | -984.88 | 1,321 | 60.59 | Upgrade
|
| Gain (Loss) on Sale of Assets | 78.14 | 6.69 | -1,640 | 216.07 | 5.33 | -152.58 | Upgrade
|
| Asset Writedown | -19.34 | -18.43 | -9.69 | -0.07 | -0.68 | -10.94 | Upgrade
|
| Pretax Income | -2,658 | -23,055 | 152,435 | 51,840 | 38.06 | 155,356 | Upgrade
|
| Income Tax Expense | -7,958 | -11,664 | 35,770 | 11,179 | -1,435 | 30,360 | Upgrade
|
| Earnings From Continuing Operations | 5,301 | -11,391 | 116,665 | 40,661 | 1,473 | 124,996 | Upgrade
|
| Minority Interest in Earnings | -6.63 | 26.76 | -228.91 | -13.83 | -12.71 | - | Upgrade
|
| Net Income | 5,294 | -11,364 | 116,436 | 40,647 | 1,460 | 124,996 | Upgrade
|
| Net Income to Common | 5,294 | -11,364 | 116,436 | 40,647 | 1,460 | 124,996 | Upgrade
|
| Net Income Growth | - | - | 186.46% | 2683.22% | -98.83% | - | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 13 | 13 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 13 | 13 | 12 | 13 | Upgrade
|
| Shares Change (YoY) | 12.54% | 3.97% | 1.69% | 4.37% | -7.21% | 67.60% | Upgrade
|
| EPS (Basic) | 370.40 | -837.42 | 9148.50 | 3244.90 | 118.75 | 10189.64 | Upgrade
|
| EPS (Diluted) | 369.71 | -837.42 | 8921.00 | 3168.00 | 118.75 | 9610.20 | Upgrade
|
| EPS Growth | - | - | 181.60% | 2567.89% | -98.76% | - | Upgrade
|
| Free Cash Flow | 1,536 | -66,577 | 116,893 | 30,651 | 1,768 | 93,340 | Upgrade
|
| Free Cash Flow Per Share | 107.17 | -4905.95 | 8955.92 | 2387.99 | 143.73 | 7041.88 | Upgrade
|
| Dividend Per Share | 500.000 | 500.000 | - | - | - | 2000.000 | Upgrade
|
| Gross Margin | 42.57% | 31.77% | 62.14% | 50.56% | 35.98% | 73.79% | Upgrade
|
| Operating Margin | -2.14% | -30.52% | 40.00% | 25.40% | -5.37% | 62.29% | Upgrade
|
| Profit Margin | 4.45% | -14.12% | 32.72% | 20.96% | 1.10% | 48.45% | Upgrade
|
| Free Cash Flow Margin | 1.29% | -82.72% | 32.85% | 15.81% | 1.34% | 36.18% | Upgrade
|
| EBITDA | 5,028 | -17,410 | 148,675 | 54,668 | -3,150 | 163,354 | Upgrade
|
| EBITDA Margin | 4.23% | -21.63% | 41.78% | 28.19% | -2.38% | 63.32% | Upgrade
|
| D&A For EBITDA | 7,580 | 7,156 | 6,335 | 5,413 | 3,956 | 2,673 | Upgrade
|
| EBIT | -2,551 | -24,566 | 142,339 | 49,255 | -7,106 | 160,680 | Upgrade
|
| EBIT Margin | -2.14% | -30.52% | 40.00% | 25.40% | -5.37% | 62.29% | Upgrade
|
| Effective Tax Rate | - | - | 23.47% | 21.57% | - | 19.54% | Upgrade
|
| Advertising Expenses | - | 246.94 | 309.9 | 325.43 | 332.29 | 105.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.